Source: Original Press Release through BusinessWire on March 20, 2017 04:28 PM Eastern Daylight Time BETHESDA, Md.–(BUSINESS WIRE)–Eighty-seven organizations...see more issued a letter today calling on Congress to take a hard look at the likely significant and life-threatening consequences of the American Health Care Act on millions of patients. The organizations represent Americans with complex health […]

Read More

Join us at the 2017 Parkinson’s Unity Walk on April 22nd. 100% of donations support research funded by six...see more major Parkinson’s foundations. Learn more at UnityWalk.org.

Read More

2016 World Parkinson Congress Leadership Forum Before the 4th World Parkinson Congress officially kicked-off in Portland, Oregon nearly 200...see more Parkinson’s Organizational Partners gathered to network and learn from each other at the first ever WPC Leadership Forum. The Forum allowed PD Advocacy Leaders to talk about their outreach, fundraising, and educational efforts and to strategize […]

Read More

APDA funded researcher published in Journal of Neuroscience – July 2016 APDA funded research demonstrates that alpha-synuclein inclusion formation...see more in neurons can be blocked and that novel therapeutic compounds targeting this process by inhibiting LRRK2 kinase activity may slow progression of PD-associated pathology. In 2013 and 2014, APDA awarded research grants to Laura Vopicelli-Daley, PhD, […]

Read More

The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis is now available...see more through NUPLAZIDconnect™ Patient Access and Support Services The American Parkinson Disease Association is pleased to share the news that ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address […]

Read More

The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with...see more Parkinson’s Disease Psychosis U.S. Commercial Launch Planned for June 2016 The American Parkinson Disease Association is pleased to share the news that ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative […]

Read More

PITTSBURGH, June 15, 2015 – Gene therapy to...see more reduce production of a brain protein successfully prevented development of Parkinson’s disease in an animal study, according to researchers at the University of Pittsburgh School of Medicine. The findings, published online today in the Journal of […]

Read More

Assemblywoman Malliotakis presents a Proclamation announcing April as “Parkinson’s Disease Awareness Month” to Leslie...see more A. Chambers (left), President & CEO of APDA, and Fred Greene (right), Chairman of the APDA Board of Directors. Today Assemblywoman Nicole Malliotakis (R,C,I-East Shore) joined the American Parkinson Disease Association (APDA) at their national headquarters, […]

Read More

APDA Partners with BioMech to Raise Funds and Get Golfers With Parkinson’s Disease Back into the Swing People with...see more Parkinson’s can enhance the joy of golf, thanks to a cutting-edge and innovative golf club! The symptoms of Parkinson’s disease can make playing golf incredibly challenging, and in some cases, impossible. BioMech Golf’s AccuLock ACE putter […]

Read More

(New York, NY, June 3, 2015) – The...see more American Parkinson Disease Association (APDA) announces it has joined The Parkinson’s Action Network (PAN) Unified Partners Program.American Parkinson Disease Association Is Proud To Join Parkinson’s Action Network’s Unified Partners Program New program allows Parkinson’s-related organizations to […]

Read More